Allogeneic Stem Cell Transplantation for Children With Sickle Cell Disease Achieves Quality of Life Similar to Normal Children and Is Cost Effective

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2013.12.096
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Allogeneic Stem Cell Transplantation for Sickle Cell Disease

Current Opinion in Hematology
Hematology
2016English

Improvement in Health-Related Quality of Life for Sickle Cell Disease Patients Treated With Chemotherapy-Free Allogeneic Hematopoietic Stem-Cell Transplantation: A Pilot Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Factors Impacting Family Decisions to Pursue Transplantation for Children With Sickle Cell Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Umbilical Cord Blood Transplantation for Children With Thalassemia and Sickle Cell Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2011English

Long-Term Outcomes After Allogeneic Stem Cell Transplantation for Children With Hematological Malignancies

Bone Marrow Transplantation
TransplantationHematology
2007English

Second Allogeneic Hematopoietic Stem Cell Transplantation in Children With Severe Aplastic Anemia

Bone Marrow Transplantation
TransplantationHematology
2015English

Similar Outcomes Between Adolescent/Young Adults and Children With AML Following Allogeneic Hematopoietic Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2013English

Sickle Cell Disease in Children

Archives of Pediatrics & Adolescent Medicine
2009English

Management of Adenovirus in Children After Allogeneic Hematopoietic Stem Cell Transplantation

Advances in Hematology
Hematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy